e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Pulmonary fibrosis - new insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of chemokine-like factor1 on murine pulmonary fibrosis
Y. Tan, D. Ma, W. Han, Y. Chen, N. Zhong (Guangzhou, Beijing, China)
Source:
Annual Congress 2004 - Pulmonary fibrosis - new insights
Session:
Pulmonary fibrosis - new insights
Session type:
Oral Presentation
Number:
3023
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Tan, D. Ma, W. Han, Y. Chen, N. Zhong (Guangzhou, Beijing, China). The effects of chemokine-like factor1 on murine pulmonary fibrosis. Eur Respir J 2004; 24: Suppl. 48, 3023
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Knowing asthma in adolescentes from Uruguaiana: The Global Asthma Network (GAN)
Primary ciliary dyskinesia and non-CF bronchiectasis
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia
Related content which might interest you:
The role of epithelium-dependent fibroblast activation in pulmonary fibrosis
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema
Source: International Congress 2017 – Experimental PH
Year: 2017
Calcium-sensing receptor as a therapeutic target for pulmonary fibrosis
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Interdependence of endothelin-1 and transforming growth factor-β
1
on Wnt3a expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
The effects of AMD3100, a CXCR4 antagonist, on the bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004
HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
Antifibrotic effects of Lck inhibition on bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 296s
Year: 2007
Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed
SOD2
expression and reduces proliferation in human primary pulmonary fibroblasts
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept